Welcome to our dedicated page for Health Catalyst news (Ticker: HCAT), a resource for investors and traders seeking the latest updates and insights on Health Catalyst stock.
Health Catalyst, Inc. reports developments tied to healthcare intelligence, data and analytics technology, and professional services for healthcare organizations. Company updates commonly cover operating results, revenue and Adjusted EBITDA guidance, and the use of AI-driven technology and domain expertise to support health systems across cost, clinical, and consumer performance.
Recurring news also includes leadership and board governance changes, shareholder-related board appointments, investor conference participation, and updates on strategic focus areas for its healthcare data platform, analytics applications, implementation, advisory, outsourcing, and improvement services.
Twistle by Health Catalyst (Nasdaq: HCAT) is enhancing access to obstetric services in Northeastern New Mexico through its partnership with the Rural OB Access & Maternal Services (ROAMS) initiative. This program utilizes Twistle's patient engagement technology to connect patients across five rural communities, allowing direct communication with care teams via mobile devices. The initiative aims to improve maternal health outcomes by reducing barriers such as travel and enhancing monitoring of conditions like gestational diabetes. Twistle's platform is HIPAA-compliant, offering personalized support and education to pre- and post-partum patients.
Health Catalyst has announced a multi-year partnership with Oklahoma Heart Hospital (OHH) aimed at enhancing revenue cycle analytics and performance. The partnership will utilize Health Catalyst's Data Operating System (DOS) platform to improve operational and clinical processes. OHH seeks to drive transparency in care costs and empower clinicians with actionable data. The collaboration is expected to position OHH for ongoing success in a changing healthcare landscape, leveraging Health Catalyst's comprehensive analytics solutions to identify trends and enhance patient care.
Health Catalyst announced a public offering of 4,245,283 shares of common stock at $53.00 per share, projected to raise approximately $225.0 million in gross proceeds. A 30-day option allows underwriters to purchase an additional 636,792 shares. The offering, led by J.P. Morgan, Goldman Sachs, and Evercore, is expected to close around August 13, 2021, pending customary conditions. This capital will support the company’s goals in healthcare data and analytics.
Health Catalyst has announced a public offering of $225 million in common stock, all of which will be offered by the company itself. The offering is contingent on market conditions and may include an option for underwriters to purchase an additional $33.75 million in shares within 30 days. J.P. Morgan, Goldman Sachs, and Evercore act as joint bookrunning managers for the offering. The public offering is conducted under an effective shelf registration and associated prospectus filed with the SEC.
Twistle by Health Catalyst (Nasdaq: HCAT) will participate in the HIMSS21 Global Conference, scheduled for August 9-13, 2021, in Las Vegas. Twistle plans to showcase its secure patient communication platform at booth #C437-38, highlighting how it can reduce health disparities and improve patient engagement. Attendees can witness live demonstrations and learn about initiatives like the #pinksocks movement, emphasizing community connection. A presentation by Tom Burton will discuss the ROI of patient engagement strategies implemented by Providence, aimed at enhancing surgical outcomes and reducing complications.
Health Catalyst (Nasdaq: HCAT) reported strong Q2 2021 financial results, exceeding revenue and Adjusted EBITDA guidance. The company achieved a positive Adjusted EBITDA of $1.7 million, marking a significant milestone since its inception. Technology revenue rose 39% to $35.5 million, while total revenue increased 38% to $59.6 million compared to Q2 2020. The recent acquisition of Twistle, effective July 1, 2021, is expected to enhance its Population Health analytics offerings. However, the company reported a net loss of $35.8 million, a 32% increase from the previous year.
Health Catalyst, a top provider of data and analytics for healthcare, announced participation in the 41st Annual Canaccord Genuity Growth Stock Conference. CFO Bryan Hunt and SVP Adam Brown will present in a fireside chat on August 11, 2021, at 2:00 p.m. ET. The company is dedicated to using data for healthcare improvements, utilizing a cloud-based platform that processes over 100 million patient records.
Health Catalyst aims for a future where all healthcare decisions are informed by data, enhancing clinical, financial, and operational outcomes.
Health Catalyst (Nasdaq: HCAT) will release its 2021 second quarter operating results on August 5, 2021, after market close. The company will host a conference call at 5 p.m. E.T. that day to discuss the results. Participants can join by calling 1-800-708-4539 (U.S.) or 1-847-619-6396 (international) using the code 50199342. A live audio webcast will be available, with a replay accessible for 90 days afterward. Health Catalyst is known for data and analytics technology that improves clinical, financial, and operational aspects for healthcare organizations.
Health Catalyst (Nasdaq: HCAT) has launched Value Optimizer, a new solution aimed at enhancing value-based care (VBC) performance for healthcare organizations. This technology addresses limitations in traditional population health tools by providing comprehensive data and insights necessary for effective VBC strategy management. Key features include a quantified view of financial opportunities, continually updated data, transparent methodologies for benchmarking, and expert guidance for maximizing performance. This solution aims to help healthcare providers lower costs while maintaining the quality of care.
Health Enterprise Partners (HEP) announced five realizations of portfolio companies and a new investment in Kno2, marking its tenth platform investment from HEP III. HEP focuses on founder-financed businesses, having previously invested in Twistle, which enhances patient engagement in healthcare. Health Catalyst (NASDAQ: HCAT) disclosed its acquisition of Twistle, enhancing its data and analytics services. Privia Health (NASDAQ: PRVA) completed a successful IPO, raising approximately $131.7 million. HEP's new investment in Kno2 will support interoperability in healthcare, aiming for better patient information exchange.